Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Obesity × Rosiglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Thyroid Cancer, Papillary 1 Solid Cancers 1 Obesity 1 Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenocarcinoma, Follicular 1

Interventions

Metformin 2 rosiglitazone-metformin combination 1 mirabegron 1 exemestane 1 atezolizumab 1 Tirzepatide 1 TIC10 compound 1 Rosiglitazone 1 Hydroquinones 1 Fish Oils 1 Docosahexaenoic Acids 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡